News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,709 Results
Type
Article (85283)
Company Profile (625)
Press Release (738801)
Section
Business (231887)
Career Advice (4091)
Deals (39623)
Drug Delivery (106)
Drug Development (90447)
Employer Resources (192)
FDA (17897)
Job Trends (17246)
News (394691)
Policy (39586)
Tag
Academia (2973)
Africa (1263)
Alliances (56346)
Alzheimer's disease (1250)
Approvals (17802)
Arizona (210)
Artificial intelligence (86)
Asia (49015)
Australia (8618)
Bankruptcy (392)
Best Places to Work (12267)
Biotechnology (438)
C2C Services and Suppliers (95111)
California (2064)
Canada (960)
Cancer (557)
Career advice (3498)
Cell therapy (145)
China (159)
Clinical research (70478)
Collaboration (160)
Colorado (88)
Compensation (85)
Connecticut (86)
COVID-19 (2756)
Cystic fibrosis (78)
Data (326)
Diabetes (92)
Diagnostics (6504)
Drug pricing (86)
Earnings (93537)
Employer resources (162)
Europe (112063)
Events (125046)
Executive appointments (167)
FDA (18137)
Florida (279)
Funding (158)
Gene therapy (110)
GLP-1 (623)
Government (5011)
Healthcare (20656)
Hotbed/Location (534575)
Illinois (324)
Indiana (163)
Infectious disease (2790)
Inflammatory bowel disease (103)
Interviews (804)
IPO (17499)
Job creations (5172)
Job search strategy (2850)
Kansas (100)
Layoffs (468)
Legal (10014)
Lung cancer (127)
Manufacturing (105)
Maryland (441)
Massachusetts (1744)
Medical device (14271)
Medtech (14276)
Mergers & acquisitions (21970)
Metabolic disorders (304)
Michigan (139)
Minnesota (236)
Neuroscience (1421)
New Jersey (626)
New York (633)
NextGen Class of 2024 (7622)
Non-profit (5054)
North Carolina (706)
Northern California (855)
Obesity (181)
Ohio (112)
Opinion (234)
Patents (83)
Pennsylvania (603)
People (63740)
Pharmaceutical (119)
Phase I (21639)
Phase II (30597)
Phase III (23120)
Pipeline (116)
Podcasts (76)
Postmarket research (3532)
Preclinical (9774)
Radiopharmaceuticals (251)
Rare diseases (143)
Real estate (7363)
Recruiting (72)
Regulatory (25613)
Research institute (2633)
Resumes & cover letters (645)
South America (1641)
Southern California (795)
Startups (4273)
Texas (272)
United States (9523)
Vaccines (573)
Washington State (284)
Weight loss (173)
Date
Last 7 days (653)
Last 30 days (2443)
Last 365 days (39757)
2024 (28372)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,709 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Transcenta Updates Encouraging Efficacy Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ESMO 2024
September 20, 2024
·
6 min read
Drug Development
Positive Phase III Results Show Xofluza Significantly Reduces the Transmission of Influenza Viruses
September 20, 2024
·
8 min read
Business
Neogen® Announces First-Quarter Earnings Release Date
September 20, 2024
·
1 min read
News
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
September 20, 2024
·
20 min read
FDA
Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy
September 20, 2024
·
2 min read
Drug Development
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ™
September 20, 2024
·
8 min read
News
Health Canada Approves CardioFlux MCG for the Diagnosis of Myocardial Ischemia
September 20, 2024
·
3 min read
Drug Development
Astellas Receives Approval from the European Commission for VYLOY™ (zolbetuximab) in Combination with Chemotherapy for Advanced Gastric and Gastroesophageal Junction Cancer
September 20, 2024
·
15 min read
News
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
September 20, 2024
·
19 min read
FDA
FDA Approves First Treatment for Niemann-Pick Disease, Type C
September 20, 2024
·
3 min read
1 of 82,471
Next